These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36116960)

  • 41. Reduction of miR-29a-3p induced cardiac ischemia reperfusion injury in mice via targeting Bax.
    Zhang L; Zhang J; Tong Q; Wang G; Dong H; Wang Z; Sun Q; Wu H
    Exp Ther Med; 2019 Sep; 18(3):1729-1737. PubMed ID: 31410131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TUG1 promotes the expression of IFITM3 in hepatocellular carcinoma by competitively binding to miR-29a.
    Liu W; Feng Q; Liao W; Li E; Wu L
    J Cancer; 2021; 12(22):6905-6920. PubMed ID: 34659578
    [No Abstract]   [Full Text] [Related]  

  • 43. MyoD is regulated by the miR-29a-Tet1 pathway in C2C12 myoblast cells.
    Chikenji A; Ando H; Nariyama M; Suga T; Iida R; Gomi K
    J Oral Sci; 2016; 58(2):219-29. PubMed ID: 27349543
    [TBL] [Abstract][Full Text] [Related]  

  • 44. circKRT7-miR-29a-3p-COL1A1 Axis Promotes Ovarian Cancer Cell Progression.
    An Q; Liu T; Wang MY; Yang YJ; Zhang ZD; Lin ZJ; Yang B
    Onco Targets Ther; 2020; 13():8963-8976. PubMed ID: 32982288
    [TBL] [Abstract][Full Text] [Related]  

  • 45. miR-29a-3p transferred by mesenchymal stem cells-derived extracellular vesicles protects against myocardial injury after severe acute pancreatitis.
    Ren S; Pan L; Yang L; Niu Z; Wang L; Feng H; Yuan M
    Life Sci; 2021 May; 272():119189. PubMed ID: 33571516
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA-29a promotes the proliferation of human nasal epithelial cells and inhibits their apoptosis and promotes the development of allergic rhinitis by down-regulating FOS expression.
    Fan Y; Tang Z; Sun J; Zhao X; Li Z; Zheng Y; Zeng X; Feng J
    PLoS One; 2021; 16(8):e0255480. PubMed ID: 34383804
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibiting MicroRNA-29a Protects Myocardial Ischemia-Reperfusion Injury by Targeting SIRT1 and Suppressing Oxidative Stress and NLRP3-Mediated Pyroptosis Pathway.
    Ding S; Liu D; Wang L; Wang G; Zhu Y
    J Pharmacol Exp Ther; 2020 Jan; 372(1):128-135. PubMed ID: 31481517
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MiR-29a Suppresses Spermatogenic Cell Apoptosis in Testicular Ischemia-Reperfusion Injury by Targeting TRPV4 Channels.
    Ning JZ; Li W; Cheng F; Yu WM; Rao T; Ruan Y; Yuan R; Zhang XB; Zhuo D; Du Y; Xiao CC
    Front Physiol; 2017; 8():966. PubMed ID: 29238305
    [No Abstract]   [Full Text] [Related]  

  • 49. lncRNA Oip5-as1 attenuates myocardial ischaemia/reperfusion injury by sponging miR-29a to activate the SIRT1/AMPK/PGC1α pathway.
    Niu X; Pu S; Ling C; Xu J; Wang J; Sun S; Yao Y; Zhang Z
    Cell Prolif; 2020 Jun; 53(6):e12818. PubMed ID: 32468629
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases.
    Yang YL; Wang FS; Li SC; Tiao MM; Huang YH
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Restoration of NRF2 attenuates myocardial ischemia reperfusion injury through mediating microRNA-29a-3p/CCNT2 axis.
    Tian R; Guan X; Qian H; Wang L; Shen Z; Fang L; Liu Z
    Biofactors; 2021 May; 47(3):414-426. PubMed ID: 33600051
    [TBL] [Abstract][Full Text] [Related]  

  • 52. miR-29a Promotes the Neurite Outgrowth of Rat Neural Stem Cells by Targeting Extracellular Matrix to Repair Brain Injury.
    Ma R; Wang M; Gao S; Zhu L; Yu L; Hu D; Zhu L; Huang W; Zhang W; Deng J; Pan J; He H; Gao Z; Xu J; Han X
    Stem Cells Dev; 2020 May; 29(9):599-614. PubMed ID: 31885334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-29a activates a multi-component growth and invasion program in glioblastoma.
    Zhao Y; Huang W; Kim TM; Jung Y; Menon LG; Xing H; Li H; Carroll RS; Park PJ; Yang HW; Johnson MD
    J Exp Clin Cancer Res; 2019 Jan; 38(1):36. PubMed ID: 30683134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. COL4A1, negatively regulated by XPD and miR-29a-3p, promotes cell proliferation, migration, invasion and epithelial-mesenchymal transition in liver cancer cells.
    Zhang H; Wang Y; Ding H
    Clin Transl Oncol; 2021 Oct; 23(10):2078-2089. PubMed ID: 33891266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. BMSC-Derived Exosomal miR-29a Promotes Angiogenesis and Osteogenesis.
    Lu GD; Cheng P; Liu T; Wang Z
    Front Cell Dev Biol; 2020; 8():608521. PubMed ID: 33363169
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dexmedetomidine Mitigates Myocardial Ischemia/Reperfusion-Induced Mitochondrial Apoptosis through Targeting lncRNA HCP5.
    Deng X; Ye F; Zeng L; Luo W; Tu S; Wang X; Zhang Z
    Am J Chin Med; 2022; 50(6):1529-1551. PubMed ID: 35931662
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MiR-29a suppresses prostate cell proliferation and induces apoptosis via KDM5B protein regulation.
    Li J; Wan X; Qiang W; Li T; Huang W; Huang S; Wu D; Li Y
    Int J Clin Exp Med; 2015; 8(4):5329-39. PubMed ID: 26131109
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LncRNA LIFR-AS1 promotes proliferation and invasion of gastric cancer cell via miR-29a-3p/COL1A2 axis.
    Pan H; Ding Y; Jiang Y; Wang X; Rao J; Zhang X; Yu H; Hou Q; Li T
    Cancer Cell Int; 2021 Jan; 21(1):7. PubMed ID: 33407453
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miR-29a Promotes Lipid Droplet and Triglyceride Formation in HCV Infection by Inducing Expression of SREBP-1c and CAV1.
    Mahdy MM; El-Ekiaby NM; Hashish RM; Salah RA; Hanafi RS; Azzazy HM; Abdelaziz AI
    J Clin Transl Hepatol; 2016 Dec; 4(4):293-299. PubMed ID: 28097097
    [No Abstract]   [Full Text] [Related]  

  • 60. MicroRNA-29a promotes colorectal cancer metastasis by regulating matrix metalloproteinase 2 and E-cadherin via KLF4.
    Tang W; Zhu Y; Gao J; Fu J; Liu C; Liu Y; Song C; Zhu S; Leng Y; Wang G; Chen W; Du P; Huang S; Zhou X; Kang J; Cui L
    Br J Cancer; 2014 Jan; 110(2):450-8. PubMed ID: 24281002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.